INTERNATIONAL SOCIETY FOR PHARMACOECONOMICS AND OUTCOMES RESEARCH (ISPOR) EXPANDS LEADERSHIP TEAM

Published Oct 28, 2015

BETSY LANE JOINS ISPOR AS CHIEF MARKETING & COMMUNICATIONS OFFICER 

Princeton, NJ—October 28, 2015—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced that Betsy Lane has been appointed director and chief marketing and communications officer for the organization. Lane will lead ISPOR’s global marketing and communications efforts to help further advance the organization’s mission to promote health economics and outcomes research excellence to improve decision making for health globally. Lane has over 25 years’ experience in the life sciences industry. Prior to joining ISPOR, she served as senior vice president, marketing and communications at Publicis Touchpoint Solutions. Previously, she worked for several medical advertising agencies leading agency teams primarily focused on specialty product launches in the oncology, endocrinology, CNS, and dermatology therapeutic areas. Lane began her career working as a pharmaceutical sales representative. While at Johnson & Johnson, she served in a variety of increasingly significant roles, including divisional sales manager and product manager. “We are excited to have Betsy join the ISPOR team,” stated Nancy Berg, chief executive officer and executive director. “Our organization has grown tremendously over the years and we believe that Betsy’s experience will help us to further our mission by more effectively communicating the great work that ISPOR does day in and day out.”

###

Related Stories

ISPOR Announces 2025-2026 Board of Directors

May 20, 2025

ISPOR announced the results of its recent elections and its 2025-2026 Board of Directors. The 2025-2026 board will assume office on July 1.

Value in Health Journal Spotlights "Whole Health" in Special Series

May 19, 2025

Value in Health, the official journal of ISPOR, announced the publication of a series of articles exploring the concept of "whole health"—a holistic approach to healthcare that extends beyond the traditional biomedical model to incorporate physical, mental, social, environmental, and spiritual dimensions of wellbeing.

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×